New research links elevated interferon-alpha levels in blood to chronic Lyme disease symptoms post-antibiotic treatment, suggesting a potential treatment pathway. Despite the study's small scale, it shifts understanding from bacterial persistence to immune response as a cause for lingering symptoms. The need for better diagnostic tests and treatments is emphasized.